Aytu BioPharma to Present at Upcoming September 2025 Conferences
-
Iran releases assets of football captain in Australia asylum row
-
French court jails Lafarge ex-CEO for funding IS in Syria
-
Atletico need 'personality' to prevent Barca comeback: Koke
-
Cameroon's Catholics divided on papal visit
-
South Africa's new DA leader vows to shed party's white image
-
Karol G honors Latinos in Coachella headline performance: 'Feel proud'
-
Pope's African tour begins in shadow of Trump ire
-
'Help me!': family's anguish over Equatorial Guinean lured into Ukraine war
-
Germany unveils 1.6 bn euro fuel price relief to tackle energy shock
-
Ukraine loan, frozen funds: how could Orban's ouster unblock EU?
-
What next for Pogacar, Van der Poel after Roubaix blow?
-
Orban loses Hungary vote to pro-Europe newcomer Magyar
-
US says to begin blockade of Iranian ports
-
Germany to cut fuel taxes amid Iran war energy shock
-
Pope Leo kicks off African tour under shadow of Trump's ire
-
Singer Luisa Sonza shares 'unique experience' of Coachella debut
-
Australia names Coyle first woman to lead army
-
Rashford with point to prove as Barca target Atletico comeback
-
Iran executed at least 1,639 people in 2025, most since 1989: NGOs
-
Nuggets roll into NBA playoffs, Raptors clinch berth
-
Flagg's sensational rookie season ends with injury
-
Trump says 'not a big fan' of Pope Leo after his anti-war message
-
Spain's Sanchez calls China trade imbalance with EU 'unsustainable'
-
Oil surges, stocks fall as Trump says to blockade Strait of Hormuz
-
Rivers departing as Bucks coach after disappointing season
-
Raptors top Nets, grab No. 5 seed on last day of NBA regular season
-
Greece's ancient sites get climate-change checkup
-
Lost film of French cinema pioneer retrieved from US attic
-
Rory-peat at Masters has McIlroy hungry for more majors
-
Liverpool seek 'special' Anfield night to salvage troubled season
-
Pope Leo XIV heads to Algeria, first stop of African tour
-
Europe reacts to Hungarian leader Orban's electoral defeat
-
Rose frustrated by latest Masters near-miss
-
Scheffler left ruing slow start after Masters record bid falls short
-
Runoff looms as Fujimori leads troubled Peru vote
-
Spain's Sanchez seeks closer China ties amid strains with US
-
Avel eCare Appoints Rich Sanders as Chief Operating Officer
-
Datavault AI Announces Upcoming Listing of Meme Coin Portfolio and Institutional RWA Token Suite on the Biconomy Exchange
-
Dr. David W. Allison Brings His Expertise in Breast and Body Surgery to Becker Aesthetics & Plastic Surgery
-
SPORT BEACH Announces Brand Advisory Board
-
David's Bridal Becomes One of the First Retailers to Enable End-to-End Purchases Within AI Chats
-
Altamira Therapeutics Announces Publication Highlighting Potential of RNA Nanoparticles for Disease-Modifying Treatment of Osteoarthritis
-
TD Joins FINOS as Platinum Member to Accelerate Open Orchestration and AI Governance in Financial Services
-
Birkenstock Announces Fiscal Second Quarter (Ended March 31, 2026) Results Date and Conference Call Scheduled for May 13, 2026
-
Elektros Highlights Surge in Used EV Demand as U.S. Market Adapts to Rising Gasoline Cost
-
Ondas Receives Initial ~$68 Million Order Under $140 Million Strategic Military Engineering Program
-
Three HEICO Subsidiaries Supply Mission-Critical Parts for Artemis II Launch
-
Solitario Resources CEO to Present at Mining Forum Europe in Zurich, Switzerland
-
Auri Inc ("AURI") New Management And Business Focus
-
Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
Aytu BioPharma to Present at Upcoming September 2025 Conferences
DENVER, CO / ACCESS Newswire / September 24, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced management will participate at the following investor conferences:
MicroCap Rodeo Fall Conference
Date: Thursday, September 25, 2025
Location: New York City
Presentation Time: 2:00 p.m. Eastern time
Webcast: https://www.webcaster5.com/Webcast/Page/3142/53024
Lytham Partners Fall 2025 Investor Conference
Date: Tuesday, September 30, 2025
Location: Virtual
Presentation Time: 2:45 p.m. Eastern time
Webcast: https://app.webinar.net/K8vDlaelmAd
Management will be participating in one-on-one meetings throughout both events. To arrange a meeting with management, please contact Robert Blum of Lytham Partners at [email protected].
About Aytu BioPharma
Aytu is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. The Company's prescription products include EXXUA™ (gepirone) extended-release tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of major depressive disorder (MDD), Adzenys XR-ODT® (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) and Cotempla XR-ODT® (methylphenidate) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of attention deficit hyperactivity disorder (ADHD), and a line of legacy products, including Karbinal® ER (carbinoxamine maleate), Poly-Vi-Flor® and Tri-Vi-Flor®. To learn more, please visit aytubio.com.
Contacts for Investors
Ryan Selhorn, Chief Financial Officer
Aytu BioPharma, Inc.
[email protected]
Robert Blum
Lytham Partners
[email protected]
SOURCE: Aytu BioPharma, Inc.
View the original press release on ACCESS Newswire
A.Clark--AT